|
1
|
|
|
2
|
|
|
3
|
|
|
4
|
- Sample Handling and Storage development sub-group
- Made recommendations on
- Samples collected
- Collection protocols and volumes
- Cross sectional assays
- Processing protocols
- Archiving of sample aliquots
- Optimal structure of UK Biobank laboratory organization (central vs local
processing)
- Testing and validation of recommended protocol
|
|
5
|
|
|
6
|
|
|
7
|
- Anticoagulants
- Haemolysis
- Clot accelerators
- Preservatives
- RNAse
- Protease inhibitors
- Fluoride oxalate
- Borate
- Azide
- Cryoprotectants
- (Central vs local processing)
- Transport and archiving temperature
|
|
8
|
|
|
9
|
|
|
10
|
|
|
11
|
|
|
12
|
- Demonstrate that the protocol produces samples that are fit for purpose
- No general degradation
- Samples are fit for a wide range of current assays
- Impact of short term freezing and controlled thawing
- Impact of delay between sample collection and cryopreservation
- Is a separate Fluoride Oxalate tube required for measures of plasma
glucose concentration?
|
|
13
|
|
|
14
|
|
|
15
|
|
|
16
|
|
|
17
|
- Integration of EBV into B-cell genome via CD21
- Existing approaches may require relatively large volumes of blood
- Cytotoxic T-cell mediated B-cell death may still be a problem (despite
use of mitogens and super antigens)
- Use B-cell selective sorting approach on small volumes of peripheral
blood (0.5ml)
|
|
18
|
|
|
19
|
|
|
20
|
- Samples maintained at 4oC for up to 36 hours prior to
processing and cryopreservation are stable although NMR analysis
indicates some systematic instability in 36 hour serum
- Samples maintained at 4oC for up to 36 hours are suitable for
a wide range of analyses
- Short term freezing and controlled thawing does not impact sample
integrity
- A separate fluoride oxalate tube is not required or measurement of
plasma glucose
- Comparative studies of RNA levels (5’ ends or whole message) will not be
possible from these samples
|
|
21
|
|